Targeted IL-22 Improves Glucose Tolerance and Reduces Hepatic Steatosis and Hepatic Fibrosis in Murine Models of Diabetes and Liver Disease

被引：0
|
作者：
Prins, John B.
Sajiir, Haressh
Keshvari, Sahar
Wong, Kuan Yau
Lockett, Jack
McGuckin, Michael
Hasnain, Sumaira Z.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-119-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice
    V. Moreira, Gabriela
    Araujo, Layanne C. C.
    Murata, Gilson M.
    Matos, Sandro L.
    Carvalho, Carla R. O.
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [2] Pioglitazone improves hepatic Steatosis and reduces the increased hepatic Glucose production in Typ-2-Diabetes
    Brehm, A.
    DIABETOLOGE, 2008, 4 (07): : 556 - 557
  • [3] Sulforaphane reduces hepatic glucose production in liver cells and improves glucose tolerance in diabetic animal models
    Axelsson, A. S.
    Tang, Y.
    Rosengren, A. H.
    DIABETOLOGIA, 2014, 57 : S350 - S350
  • [4] A liver-targeted acetyl CoA carboxylase inhibitor reduces hepatic steatosis and liver injury in a murine model of NASH
    Bates, J.
    Brockett, R.
    Mikaelian, I.
    Wang, T.
    Ray, A.
    Tumas, D.
    Breckenridge, D.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S430 - S430
  • [5] Inhibition of the expression of Grb14 in liver improves glucose tolerance and hepatic steatosis in mice.
    Carre, N.
    Popineau, L.
    Cauezac, M.
    Fauveau, V.
    Postic, C.
    Girard, J.
    Burnol, A. F.
    DIABETES & METABOLISM, 2010, 36 : A12 - A12
  • [6] ULTRASOUND FOR THE DETECTION OF HEPATIC STEATOSIS AND FIBROSIS IN LIVER-DISEASE
    SAVERYMUTTU, SH
    JOSEPH, AE
    MAXWELL, JD
    GUT, 1985, 26 (05) : A569 - A569
  • [7] Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver
    Huang, Yeping
    Yu, Fan
    Ding, Yue
    Zhang, Hong
    Li, Xinyue
    Wang, Xiao
    Wu, Xiaoshan
    Xu, Jie
    Wang, Liang
    Tian, Chenxu
    Jiang, Min
    Zhang, Rong
    Yan, Chenyan
    Song, Yingxiang
    Huang, Haijun
    Xu, Guangzhong
    Ding, Qiurong
    Ye, Xiao
    Lu, Yan
    Hu, Cheng
    HEPATOLOGY, 2024,
  • [8] GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
    Loomba, Rohit
    Kayali, Zeid
    Noureddin, Mazen
    Ruane, Peter
    Lawitz, Eric J.
    Bennett, Michael
    Wang, Lulu
    Harting, Eliza
    Tarrant, Jacqueline M.
    McColgan, Bryan J.
    Chung, Chuhan
    Ray, Adrian S.
    Subramanian, G. Mani
    Myers, Robert P.
    Middleton, Michael S.
    Lai, Michelle
    Charlton, Michael
    Harrison, Stephen A.
    GASTROENTEROLOGY, 2018, 155 (05) : 1463 - +
  • [9] Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease
    Kjeldsen, Sasha A. S.
    Werge, Mikkel P.
    Grandt, Josephine
    Richter, Michael M.
    Thing, Mira
    Hetland, Liv E.
    Rashu, Elias B.
    Jensen, Anne-Sofie H.
    Winther-Sorensen, Marie
    Kellemann, Jesper Sloth
    Holst, Jens J.
    Junker, Anders E.
    Serizawa, Reza R.
    Vyberg, Mogens
    Gluud, Lise Lotte
    Albrechtsen, Nicolai J. Wewer
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2024, 327 (04): : G558 - G570
  • [10] XANTHOHUMOL IMPROVES GLUCOSE TOLERANCE AND INHIBITS HEPATIC STEATOSIS, INFLAMMATION AND FIBROGENESIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Dorn, C.
    Hellerbrand, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S488 - S488
12345